Home > Financial Ratios > WINDLAS BIOTECH

WINDLAS BIOTECH
Price to Cash Earnings (PCE)

    Back to All Ratios
WINDLAS BIOTECH is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for WINDLAS BIOTECH
Please provide your vote to see the results

WINDLAS BIOTECH Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   PCE(x) 14.888.579.11--

What is the latest Price to Cash Earnings (PCE) ratio of WINDLAS BIOTECH ?

The latest Price to Cash Earnings (PCE) ratio of WINDLAS BIOTECH is 14.88 based on Mar2024 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202414.88
Mar20238.57
Mar20229.11
Mar2021-
Mar2020-

How is Price to Cash Earnings (PCE) of WINDLAS BIOTECH Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2024 14.88
73.63
Mar2023 8.57
-5.93
Mar2022 9.11
0
Mar2021 0
0
Mar2020 0 -

Other Financial Ratios of WINDLAS BIOTECH


Compare Price to Cash Earnings (PCE) ratio of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹2,034.6 Cr -3% -7.3% 77.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹438,778.0 Cr 2.3% 5.6% 21.7% Stock Analytics
DIVIS LABORATORIES ₹161,949.0 Cr 1.5% 4.2% 51.2% Stock Analytics
CIPLA ₹123,222.0 Cr 0% 2.9% 10% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,205.0 Cr 0.6% 0.9% 23.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,707.7 Cr 0.8% 1.8% -5.4% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

-3%

-7.3%

77.2%

SENSEX

0.9%

4.2%

8.3%


You may also like the below Video Courses